Effect of a Single High Dose of Vitamin D3 in Patients With Moderate to Severe COVID-19
posted 14 hours
Mashup Score: 36
JAMA Network - This randomized trial compares the effects of a single 200 000-IU dose of vitamin D3 vs placebo on length of stay in patients hospitalized with...
JAMA Network - This JAMA Patient Page describes the types, causes, and treatment of nystagmus, a rhythmic involuntary movement of the...
Nystagmus is a rhythmic involuntary movement of the eyes that can be associated with vertigo, to-and-fro illusions of motion, and blurry vision. It can be primary or secondary to other disease or medications https://t.co/nt29TWNWgE @malcolmkates @UFMedicine
COVID-19 Case-Fatality Rate and Characteristics of Patients Dying in Italy
posted 1 day
Mashup Score: 6
JAMA Network - This Viewpoint from physicians with the Italian National Institute of Health confirms a higher case-fatality rate from coronavirus disease 2019 (COVID-19) in Italy compared...
COVID-19 Case-Fatality Rate and Characteristics of Patients Dying in Italy https://t.co/bRmEdCOawy #MostCited
JAMA Network - Rimegepant is safe and effective for preventing migraines, a phase 2 and 3 trial published in The Lancet reported. The orally administered calcitonin gene–related...
Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, is safe & effective for preventing migraines in a new phase 3 trial. It's already approved for acute treatment; no oral drugs are currently approved to both prevent & treat migraine https://t.co/VSXXZTgGKa
JAMA Network - A 48-year-old man had erythema without warmth over his right ankle and dorsomedial foot, with nontender, nonpalpable purpura over the foot dorsum and scattered...
A 48 yo man had nontender, nonpalpable purpura over his foot dorsum and scattered petechiae over his RLE 6 weeks after an ankle fracture; temp was 38.2 C (100.8 F). What is the diagnosis and what would you do next? https://t.co/1aLebWTODJ @BIDMChealth @UWMedicine
AMA EdHub - The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the...
The @pfizer-@BioNTech_Group and @moderna_tx #COVID19 mRNA vaccines are the first of many being tested for widespread use. @buddycreech, director of @VanderbiltU Vaccine Research Program, reviews these and other vaccines likely to become available https://t.co/paCivATMqH
A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events
posted 18 hours
Mashup Score: 3
JAMA Network - This Viewpoint reviews the system in place to compensate US residents for proven vaccine injury via the Countermeasures Injury Compensation Program and emphasizes that...
No medical intervention, including vaccines, is 100% free of adverse reactions in 100% of recipients, but people should understand the benefit of vaccines to individuals and society far exceed risks of harm https://t.co/CArK16rsAW @TuftsMedSchool
JAMA Network - Informational videos starring physicians modestly improved coronavirus disease 2019 (COVID-19) knowledge among US Black and Latino adults regardless of the clinician’s race, according to...
Info videos featuring docs modestly improved #COVID19 knowledge among US Black & Latino adults regardless of the clinician’s race, in a new trial. The 3 videos covered basics about the virus and the importance of social distancing, hygiene, face masks https://t.co/qEFkXLGJJd
Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2
posted 8 hours
Mashup Score: 1
JAMA Network - This study compares titers of binding and neutralizing antibodies after a single mRNA coronavirus vaccine dose in health care workers previously infected with...
HCWs at @UMMC w serology-defined prior #COVID19 infection had higher Ab titer responses to single-dose mRNA vaccine vs those not previously infected, informing proposals that the former might be protected w single-dose vax, or be lower priority https://t.co/7TYvbCl494
JAMA Network - This JAMA Patient Page explains how the Johnson & Johnson COVID-19 vaccine, likely to be the third SARS-CoV-2 vaccine approved for widespread use, uses...
The @US_FDA has authorized use of the JNJ/Janssen vaccine. The gene for the #SARSCoV2 spike protein is added to the DNA of a replication-disabled adenovirus 26 virus, which with vaccination infects host cells and induces production of CoV spike protein https://t.co/2Re7pnc9XX
RT @ProaArrixaca: Effect of a Single High Dose of Vitamin D3 in Patients With Moderate to Severe COVID-19 https://t.co/2TXDkkGtCv via @JAMA…